Development of mitoxantrone


Mitoxantrone (Novantrone®; dihydroxyanthracenedione) belongs to a new structural class of antineoplastic agents, the anthracenediones. It was the outcome of a program in synthetic chemistry, at the Medical Research Division of the American Cyanamid Company, which started from a molecule with structural features predicted to favor intercalation with double… (More)
DOI: 10.1007/BF00174154

2 Figures and Tables


  • Presentations referencing similar topics